These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6441488)

  • 1. Characterization of dermonecrotic toxin produced by serotype D strains of Pasteurella multocida.
    Nakai T; Sawata A; Tsuji M; Kume K
    Am J Vet Res; 1984 Nov; 45(11):2410-3. PubMed ID: 6441488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular locations of dermonecrotic toxins in Pasteurella multocida and in Bordetella bronchiseptica.
    Nakai T; Sawata A; Kume K
    Am J Vet Res; 1985 Apr; 46(4):870-4. PubMed ID: 4014837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of nasal turbinate atrophy in germ-free pigs, using Pasteurella multocida as well as bacterium-free crude and purified dermonecrotic toxin of P multocida.
    Kamp EM; Kimman TG
    Am J Vet Res; 1988 Nov; 49(11):1844-9. PubMed ID: 3247905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virulence of Pasteurella multocida in atrophic rhinitis of gnotobiotic pigs infected with Bordetella bronchiseptica.
    Rutter JM
    Res Vet Sci; 1983 May; 34(3):287-95. PubMed ID: 6878879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the dermonecrotic toxin by Bordetella bronchiseptica is not necessary for predisposing to infection with toxigenic Pasteurella multocida.
    Brockmeier SL; Register KB
    Vet Microbiol; 2007 Dec; 125(3-4):284-9. PubMed ID: 17624695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical Pasteurella strains producing a toxin similar to the dermonecrotic toxin of Pasteurella multocida subspecies multocida.
    Kamp EM; ter Laak EA; de Jong MF
    Vet Rec; 1990 Apr; 126(17):434-7. PubMed ID: 2111955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the toxin-producing ability of Pasteurella multocida in mice.
    Magyar T
    Acta Vet Hung; 1989; 37(4):319-25. PubMed ID: 2638810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Isolation and certain properties of the dermonecrotic toxin from Pasteurella multocida].
    Kalmykova LI; Ezepchuk IuV; Shegidevich EA; Navasardiants DG
    Mol Gen Mikrobiol Virusol; 1991 Aug; (8):29-32. PubMed ID: 1784303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and pathological effects of the dermonecrotic toxin of Bordetella bronchiseptica and Pasteurella multocida in specific-pathogen-free piglets.
    Eliás B; Boros G; Albert M; Tuboly S; Gergely P; Papp L; Barna Vetró I; Rafai P; Molnár E
    Nihon Juigaku Zasshi; 1990 Aug; 52(4):677-88. PubMed ID: 2144027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence of Pasteurella multocida or Bordetella bronchiseptica to the swine nasal epithelial cell in vitro.
    Nakai T; Kume K; Yoshikawa H; Oyamada T; Yoshikawa T
    Infect Immun; 1988 Jan; 56(1):234-40. PubMed ID: 3335403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical verification of a multiplex PCR for identification of Bordetella bronchiseptica and Pasteurella multocida from swine.
    Register KB; DeJong KD
    Vet Microbiol; 2006 Oct; 117(2-4):201-10. PubMed ID: 16782287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence of Bordetella bronchiseptica and Pasteurella multocida to swine nasal ciliated epithelial cells in vitro.
    Chung WB; Collins MT; Bäckström LR
    APMIS; 1990 May; 98(5):453-61. PubMed ID: 2357345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic relationship between the dermonecrotic toxins produced by Pasteurella multocida type D and type A.
    Frymus T; Müller E; Petzoldt K
    Zentralbl Veterinarmed B; 1989 May; 36(3):199-202. PubMed ID: 2763756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of dermonecrotic toxin prepared from sonic extracts Bordetella bronchiseptica.
    Kume K; Nakai T; Samejima Y; Sugimoto C
    Infect Immun; 1986 May; 52(2):370-7. PubMed ID: 3699886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum haptoglobin concentration in growing swine after intranasal challenge with Bordetella bronchiseptica and toxigenic Pasteurella multocida type D.
    Francisco CJ; Shryock TR; Bane DP; Unverzagt L
    Can J Vet Res; 1996 Jul; 60(3):222-7. PubMed ID: 8809387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological and protective effects of Bordetella bronchiseptica subunit vaccines based on the recombinant N-terminal domain of dermonecrotic toxin.
    Wang C; Liu L; Zhang Z; Yan Z; Yu C; Shao M; Jiang X; Chi S; Wei K; Zhu R
    Int Immunopharmacol; 2015 Oct; 28(2):952-9. PubMed ID: 26337750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence of Pasteurella multocida isolated from pigs and relationship with capsular type and dermonecrotic toxin production.
    Vena MM; Blanchard B; Thomas D; Kobisch M
    Ann Rech Vet; 1991; 22(2):211-8. PubMed ID: 1897871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between Bordetella bronchiseptica and toxigenic Pasteurella multocida on the nasal mucosa of SPF piglets.
    Eliás B; Albert M; Tuboly S; Rafai P
    J Vet Med Sci; 1992 Dec; 54(6):1105-10. PubMed ID: 1477161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and characterization of the dermonecrotic toxin gene of Bordetella bronchiseptica].
    Xue Y; Zhao Z; Pei J; Wang C; Ding K; Cheng X
    Sheng Wu Gong Cheng Xue Bao; 2011 Dec; 27(12):1722-8. PubMed ID: 22506412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification of dermonecrotic toxin from a sonic extract of Pasteurella multocida SP-72 serotype D.
    Nakai T; Sawata A; Tsuji M; Samejima Y; Kume K
    Infect Immun; 1984 Nov; 46(2):429-34. PubMed ID: 6542070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.